CoChat

Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis

Open access
Xin, Wen-Xiu, Fang, Luo, Fang, Qi-Lu, Zheng, Xiao-Wei, Ding, Hai-Ying, Huang, Ping · 2018 · Medicine

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

BACKGROUND: To assess the association between hypoglycemic agents and prognosis of lung cancer patients with diabetes. METHODS: A comprehensive literature search was performed in PubMed, Web of Science, Embase, and Cochrane Library until May 2017. The search yielded 2593 unique citations, of which 18 articles met inclusion criteria. The hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated by a fixed-effects or random-effects model. RESULTS: The pooled HRs favoring metformin users were 0.77 for overall survival (OS) (n = 15, 95% CI: 0.68-0.86) and 0.50 for disease-free survival (n = 5, 95% CI: 0.39-0.64). One study assessed the relationship between metformin and cancer-specific survival (CSS), reporting no significant results. No significant association between insulin and OS (n = 2, HR: 0.95, 95% CI: 0.79-1.13) or CSS (n = 2, HR: 1.03, 95% CI: 0.76-1.41) was noted. One study evaluated association of sulfonylureas with lung cancer survival and reported no clinical benefit (HR: 1.10, 95% CI: 0.87-1.40). One study reported no association of thiazolidinediones with lung cancer survival (HR: 1.04, 95% CI: 0.65-1.66). CONCLUSIONS: This meta-analysis demonstrated that metformin exposure might improve survival outcomes in lung cancer patients with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000010035

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart the process of selecting the final 18 publications.
Figure 1 Flowchart the process of selecting the final 18 publications.CC BY-ND · PubMed Central
Figure 2 Forest plots on the association of metformin use with survival outcomes for patients with lung cancer: (A) OS; (B) DFS. DFS = disease-free survival, OS = overall survival.
Figure 2 Forest plots on the association of metformin use with survival outcomes for patients with lung cancer: (A) OS; (B) DFS. DFS = disease-free survival, OS = overall survival.CC BY-ND · PubMed Central
Figure 3 Forest plots on the association of insulin use with survival outcomes for patients with lung cancer: (A) OS; (B) CSS. CSS = cancer-specific survival, OS = overall survival.
Figure 3 Forest plots on the association of insulin use with survival outcomes for patients with lung cancer: (A) OS; (B) CSS. CSS = cancer-specific survival, OS = overall survival.CC BY-ND · PubMed Central
Figure 4 Funnel plot analyses for publication bias: (A) OS; (B) DFS. DFS = disease-free survival, OS = overall survival.
Figure 4 Funnel plot analyses for publication bias: (A) OS; (B) DFS. DFS = disease-free survival, OS = overall survival.CC BY-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 1

  1. Synan, 2009, Thiazolidinediones (TZDs) inhibit the expression of pro-angiogenic ELR plus CXC chemokines in non-small cell lung cancer (NSCLC) cells via a PPAR-gamma independent mechanism, Am J Respir Crit Care Med, 179, A5007

Cited by

See all 18

Metadata

Authors
Xin, W.-X., Fang, L., Fang, Q.-L., Zheng, X.-W., Ding, H.-Y., & Huang, P.
Affiliations
Zhejiang Cancer Hospital (CN)
Corresponding author
Huang, Ping
Venue
Medicine
Published
2018-03
Volume
97
Issue
9
Pages
e0035
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2790803409
Cited by
18
References
42
Citations by year
2026: 1 · 2025: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 2
FWCI
0.27
Type
journal article
Language
en
Open access
Licence
cc-by-nd
Locations
  • Medicine (publishedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by-nd)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords
antidiabetic drugs, lung cancer, diabetes mellitus, metformin, insulin, sulfonylureas, thiazolidinediones, overall survival, disease-free survival, cancer-specific survival, prognosis
MeSH terms
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin, Lung Neoplasms, Metformin, Prognosis, Sulfonylurea Compounds, Thiazolidinediones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis. https://app.cochat.ai/papers/10.1097/md.0000000000010035
The paper
Xin, W.-X., Fang, L., Fang, Q.-L., Zheng, X.-W., Ding, H.-Y., & Huang, P. (2018). Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis. Medicine. https://doi.org/10.1097/md.0000000000010035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.